MASSACHUSETTS — Several startups with roots in Massachusetts are worth keeping an eye on as they respond to some of the nation’s most vexing problems, Inc. magazine said with the release of its 2023 Inc. 5000 list.
The startup companies were ranked by revenue growth from 2019 to 2022. To be considered, they had to have earned at least $100,000 in 2019 and grown that to at least $2 million by the end of 2022.
Read more: https://patch.com/massachusetts/across-ma/startups-ma-make-inc
Intended Use Modus-F by StemWave: The Modus-F by StemWave, utilizing Cellular Response Technology, is intended for use in addressing minor aches and pains in accordance with the User Manual (IFU). Use of the product for any other purpose has not been reviewed by the U.S. Food and Drug Administration and is considered off-label use. Please consult the User Manual (IFU) and all labeling provided with the product prior to use.
Individual results may vary. Neither StemWave nor any of its subsidiaries dispense medical advice. The contents of this website do not constitute medical, legal, or any other type of professional advice. Information related to various health, medical, and fitness conditions and their treatment is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.
Hear patients share their experience with StemWave in their pain treatment journey
Hear from medical providers about StemWave’s impact on their practice and profits
By using our website you agree to our
